Cytophage Technologies Ltd.
CPTCF
$0.19
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 09/30/2023 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -34.72% | -34.97% | -- | ||
| Total Receivables | 6.87% | -4.58% | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 31.25% | -54.72% | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -27.26% | -53.74% | -- | ||
| Total Current Assets | -30.59% | -33.86% | -- | ||
|
|
|||||
| Total Current Assets | -30.59% | -33.86% | -- | ||
| Net Property, Plant & Equipment | 5.86% | 24.26% | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | -- | -- | -- | ||
| Total Assets | -14.96% | -17.26% | -- | ||
|
|
|||||
| Total Accounts Payable | -12.15% | -11.42% | -- | ||
| Total Accrued Expenses | -0.72% | -34.47% | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 1.28% | -8.97% | -- | ||
| Total Finance Division Other Current Liabilities | -- | -- | -- | ||
| Total Other Current Liabilities | -- | -- | -- | ||
| Total Current Liabilities | -3.74% | -17.50% | -- | ||
|
|
|||||
| Total Current Liabilities | -3.74% | -17.50% | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -2.45% | -4.53% | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | -2.90% | -9.46% | -- | ||
|
|
|||||
| Common Stock & APIC | 1.73% | -1.00% | -- | ||
| Retained Earnings | -5.79% | -4.22% | -- | ||
| Treasury Stock & Other | -0.93% | -1.29% | -- | ||
| Total Common Equity | -19.66% | -19.95% | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | -19.66% | -19.95% | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | -19.66% | -19.95% | -- | ||
|
|
|||||